Meridian Bioscience reported $1.4B in Market Capitalization this November of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Abbott ABT:US USD 169.45B 20.79B
Accelerate Diagnostics AXDX:US USD 152M 73M
Atrion ATRI:US USD 1.13B 140M
Becton, Dickinson and BDX:US USD 63.55B 6.76B
Bio Rad Laboratories BIO:US USD 12.4B 2.31B
Cerus CERS:US USD 638M 298M
Meridian Bioscience VIVO:US USD 1.38B 53M
Myriad Genetics MYGN:US USD 1.54B 74M
Neogen NEOG:US USD 3.02B 421M
Orasure Technologies OSUR:US USD 275M 79M
Quidel QDEL:US USD 4.79B 1.72B
Rockwell Medical RMTI:US USD 15M 3M
Sientra SIEN:US USD 40M 13M
Staar Surgical STAA:US USD 3.39B 2M
Thermo Fisher Scientific TMO:US USD 198.71B 13.96B
Trinity Biotech TRIB:US USD 22M 4M
Utah Medical Products UTMD:US USD 309M 4M